Patients using less than 5 mg of prenisolone per day to treat inflammatory disease had nearly double the odds of developing cardiovascular disease or experiencing an adverse heart or vascular event.
Argentum releases infection control program guidance for assisted living providers … Behavioral counseling the focus of new cardiovascular disease guidelines … Poll: Most older adults intend to get COVID vaccine — eventually … Monitoring technology reduces falls in senior living operation by 80%: Podcast interview … Geriatric depression scale less accurate in adults with cognitive…
Adults who took a daily combination pill containing statins and blood-pressure–lowering drugs, plus daily aspirin, were less likely to experience heart attack, stroke, and death from cardiovascular causes.
A seven-year trial shows that the phosphate binder lanthanum carbonate (Fosrenol) does not reduce cardiovascular risk for late-stage renal patients, researchers say.
Over consecutive flu seasons, patients with diabetes who were vaccinated had a significantly reduced risk of all-cause death, cardiovascular mortality, and death from heart attack or stroke.
The risk of dying from a heart attack or stroke was lower by 20% in elders who took statins. In fact, age and dementia diagnosis had no bearing on statin benefits, say researchers.
New evidence ties chronic conditions to severe COVID-19 illness, and New Orleans is a case in point, say health officials.
Folate levels linked to lower cardiovascular mortality risk in arthritis … Trial drug eases chronic cough symptoms… Lack of evidence stymies guidance for dementia screening in asymptomatic adults
Weight gain was not a problem in mice fed a high-fat, high-protein diet. But their cardiovascular health suffered, say investigators.
People who have not experienced a heart attack or stroke should not consume aspirin each day for prevention, say researchers.
